Cargando…
Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy
Acute myocardial infarction (AMI) is a multifaceted syndrome influenced by the functions of various extrinsic and intrinsic pathways and pathological processes, which can be detected in circulation using biomarkers. In this study, we investigated the secretome protein profile of induced-hypertrophy...
Autores principales: | Mahmud, Joyeta, Ong, Hien Thi My, Ates, Eda, Seo, Hong Seog, Kang, Min-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315568/ https://www.ncbi.nlm.nih.gov/pubmed/36977605 http://dx.doi.org/10.5483/BMBRep.2022-0194 |
Ejemplares similares
-
Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
por: Wang, Ting, et al.
Publicado: (2021) -
Screening of Natural Compounds for CYP11A1 Stimulation Against Cell Renal Cell Carcinoma
por: Ong, Hien Thi My, et al.
Publicado: (2023) -
Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer
por: Hatzipetros, Ioannis, et al.
Publicado: (2013) -
Over-expression of 14-3-3zeta is an early event in oral cancer
por: Matta, Ajay, et al.
Publicado: (2007) -
Overexpression of CYP11A1 recovers cell cycle distribution in renal cell carcinoma Caki-1
por: Ong, Hien Thi My, et al.
Publicado: (2022)